Greg Brophy, President & CEO

BioDlogics is engaged in the development and commercialization of novel osteobiologics and various wound covering products derived from the placental tissues.

Its research and development efforts are focused on the regenerative potential of amnion and the other placental tissues given their unique biologic structure, rich source of undifferentiated stem cells, and the unique immune privilege that characterizes their function in the body. From the recovery of tissue from live, healthy donors during childbirth to the development of new products that will improve patient outcomes, BioDlogics is committed to enhancing the regenerative potential of the human body.